Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability

Frontiers in Behavioral Neuroscience

Volumn 9, Issue september, 2015, Pages

  Häring, Martin ^a   Enk, Vanessa ^a   Rey, Alejandro Aparisi ^a   Loch, Sebastian ^a   de Azua, Inigo Ruiz ^a   Weber, Tillmann ^b   Bartsch, Dusan ^b   Monory, Krisztina ^a   Lutz, Beat ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anxiety; CB1 receptor; Raphe nuclei; Serotonin; Sociability

Indexed keywords

CANNABINOID 1 RECEPTOR; CRE RECOMBINASE; SEROTONIN; TAMOXIFEN; TRYPTOPHAN HYDROXYLASE 2;

ACUTE STRESS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; AVERSION; CB1 RECEPTOR GENE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; GENE INACTIVATION; GENETIC RECOMBINATION; LOCOMOTION; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; RAPHE NUCLEUS; SEROTONINERGIC NERVE CELL; SIGNAL TRANSDUCTION; SOCIAL INTERACTION; TPH2 GENE;

EID: 84940989383     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2015.00235     Document Type: Article

References (62)

1. Amilhon, B., Lepicard, E., Renoir, T., Mongeau, R., Popa, D., Poirel, O., et al. (2010). VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. J. Neurosci. 30, 2198-2210. doi: 10.1523/JNEUROSCI.5196-09.2010
2. Asan, E., Steinke, M., and Lesch, K. P. (2013). Serotonergic innervation of the amygdala: targets, receptors and implications for stress and anxiety. Histochem. Cell Biol. 139, 785-813. doi: 10.1007/s00418-013-1081-1
3. Bailey, K. R., and Crawley, J. N. (2009). "Anxiety-related behaviors in mice," inMethods of Behavior Analysis in Neuroscience, ed. J. J. Buccafusco (Boca Raton. FL: CRC Press), 77-101.
4. Baker, K. G., Halliday, G. M., Halasz, P., Hornung, J. P., Geffen, L. B., Cotton, R. G., et al. (1991). Cytoarchitecture of serotonin-synthesizing neurons in the pontine tegmentum of the human brain. Synapse 7, 301-320. doi: 10.1002/syn.890070407
5. Bambico, F. R., Katz, N., Debonnel, G., and Gobbi, G. (2007). Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J. Neurosci. 27, 11700-11711. doi: 10.1523/jneurosci.1636-07.2007
6. Bellocchio, L., Soria-Gómez, E., Quarta, C., Metna-Laurent, M., Cardinal, P., Binder, E., et al. (2013). Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB_1 receptor blockade. Proc. Natl. Acad. Sci. U S A 110, 4786-4791. doi: 10.1073/pnas.1218573110
7. Belzung, C., Misslin, R., Vogel, E., Dodd, R. H., and Chapouthier, G. (1987). Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light/dark choice situation.Pharmacol. Biochem. Behav. 28, 29-33. doi: 10.1016/0091-3057(87)90006-2
8. Bodnoff, S. R., Suranyi-Cadotte, B. E., Quirion, R., and Meaney, M. J. (1989). Role of the central benzodiazepine receptor system in behavioral habituation to novelty.Behav. Neurosci. 103, 209-212. doi: 10.1037/0735-7044.103.1.209
9. Borsini, F., and Meli, A. (1988). Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 94, 147-160. doi: 10.1007/bf00176837
10. Broekkamp, C. L., Rijk, H. W., Joly-Gelouin, D., and Lloyd, K. L. (1986). Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice. Eur. J. Pharmacol. 126, 223-229. doi: 10.1016/0014-2999(86)90051-8
11. Canli, T., and Lesch, K. P. (2007). Long story short: the serotonin transporter in emotion regulation and social cognition. Nat. Neurosci. 10, 1103-1109. doi: 10.1038/nn1964
12. Carkaci-Salli, N., Salli, U., Kuntz-Melcavage, K. L., Pennock, M. M., Ozgen, H., Tekin, I., et al. (2011). TPH2 in the ventral tegmental area of the male rat brain. Brain Res. Bull. 84, 376-380. doi: 10.1016/j.brainresbull.2011.01.006
13. Celada, P., Puig, M. V., and Artigas, F. (2013). Serotonin modulation of cortical neurons and networks. Front. Integr. Neurosci. 7:25. doi: 10.3389/fnint.2013.00025
14. Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., and Artigas, F. (2001). Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A) and glutamate receptors. J. Neurosci. 21, 9917-9929.
15. Cools, R., Roberts, A. C., and Robbins, T. W. (2008). Serotoninergic regulation of emotional and behavioral control processes. Trends Cogn. Sci. 12, 31-40. doi: 10.1016/j.tics.2007.10.011
16. Coplan, J. D., Gopinath, S., Abdallah, C. G., and Berry, B. R. (2014). A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy. Front. Behav. Neurosci. 8:189. doi: 10.3389/fnbeh.2014.00189
17. Dubreucq, S., Matias, I., Cardinal, P., Häring, M., Lutz, B., Marsicano, G., et al. (2012). Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice. Neuropsychopharmacology 37, 1885-1900. doi: 10.1038/npp.2012.36
18. Ennaceur, A., and Delacour, J. (1988). A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data. Behav. Brain Res. 31, 47-59. doi: 10.1016/0166-4328(88)90157-x
19. Ferreira, S. G., Teixeira, F. M., Garção, P., Agostinho, P., Ledent, C., Cortes, L., et al. (2012). Presynaptic CB1 cannabinoid receptors control frontocortical serotonin and glutamate release-species differences. Neurochem. Int. 61, 219-226. doi: 10.1016/j.neuint.2012.05.009
20. Gobbi, G., Bambico, F. R., Mangieri, R., Bortolato, M., Campolongo, P., Solinas, M., et al. (2005). Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. U S A 102, 18620-18625. doi: 10.1073/pnas.0509591102
21. Goyens, J., and Noirot, E. (1975). Effects of cohabitation with females on aggressive behavior between male mice. Dev. Psychobiol. 8, 79-84. doi: 10.1002/dev.420080111
22. Haenisch, B., and Bönisch, H. (2011). Pharmacological characterization of tegaserod at the wild type and 124Cys variant of the human 5-HT1B receptor. Pharmacogenet. Genomics 21, 432-435. doi: 10.1097/FPC.0b013e3283469f1d
23. Haj-Dahmane, S., and Shen, R. Y. (2005). The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling. J. Neurosci. 25, 896-905. doi: 10.1523/jneurosci.3258-04.2005
24. Haj-Dahmane, S., and Shen, R. Y. (2009). Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors. J. Pharmacol. Exp. Ther. 331, 186-196. doi: 10.1124/jpet.109.153858
25. Haj-Dahmane, S., and Shen, R. Y. (2011). Modulation of the serotonin system by endocannabinoid signaling. Neuropharmacology 61, 414-420. doi: 10.1016/j.neuropharm.2011.02.016
26. Hájos, N., and Freund, T. F. (2002). Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem. Phys. Lipids 121, 73-82. doi: 10.1016/s0009-3084(02)00149-4
27. Hanks, J. B., and González-Maeso, J. (2013). Animal models of serotonergic psychedelics. ACS Chem. Neurosci. 4, 33-42. doi: 10.1021/cn300138m
28. Häring, M., Grieb, M., Monory, K., Lutz, B., and Moreira, F. A. (2013). Cannabinoid CB1 receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations. Neuropharmacology 65, 83-89. doi: 10.1016/j.neuropharm.2012.09.002
29. Häring, M., Guggenhuber, S., and Lutz, B. (2012). Neuronal populations mediating the effects of endocannabinoids on stress and emotionality. Neuroscience 204, 145-158. doi: 10.1016/j.neuroscience.2011.12.035
30. Häring, M., Kaiser, N., Monory, K., and Lutz, B. (2011). Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration. PLoS One 6:e26617. doi: 10.1371/journal.pone.0026617
31. Häring, M., Marsicano, G., Lutz, B., and Monory, K. (2007). Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice.Neuroscience 146, 1212-1219. doi: 10.1016/j.neuroscience.2007.02.021
32. Heiming, R. S., Jansen, F., Lewejohann, L., Kaiser, S., Schmitt, A., Lesch, K. P., et al. (2009). Living in a dangerous world: the shaping of behavioral profile by early environment and 5-HTT genotype. Front. Behav. Neurosci. 3:26. doi: 10.3389/neuro.08.026.2009
33. Heisler, L. K., Chu, H. M., Brennan, T. J., Danao, J. A., Bajwa, P., Parsons, L. H., et al. (1998). Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl. Acad. Sci. U S A 95, 15049-15054. doi: 10.1073/pnas.95.25.15049
34. Homberg, J. R., and Lesch, K. P. (2011). Looking on the bright side of serotonin transporter gene variation. Biol. Psychiatry 69, 513-519. doi: 10.1016/j.biopsych.2010.09.024
35. Jacob, W., Yassouridis, A., Marsicano, G., Monory, K., Lutz, B., and Wotjak, C. T. (2009). Endocannabinoids render exploratory behavior largely independent of the test aversiveness: role of glutamatergic transmission. Genes Brain Behav. 8, 685-698. doi: 10.1111/j.1601-183x.2009.00512.x
36. Jansen, F., Heiming, R. S., Kloke, V., Kaiser, S., Palme, R., Lesch, K. P., et al. (2011). Away game or home match: the influence of venue and serotonin transporter genotype on the display of offensive aggression. Behav. Brain Res. 219, 291-301. doi: 10.1016/j.bbr.2011.01.029
37. Jansen, F., Heiming, R. S., Lewejohann, L., Touma, C., Palme, R., Schmitt, A., et al. (2010). Modulation of behavioral profile and stress response by 5-HTT genotype and social experience in adulthood. Behav. Brain Res. 207, 21-29. doi: 10.1016/j.bbr.2009.09.033
38. Jia, Y. F., Song, N. N., Mao, R. R., Li, J. N., Zhang, Q., Huang, Y., et al. (2014). Abnormal anxiety- and depression-like behaviors in mice lacking both central serotonergic neurons and pancreatic islet cells. Front. Behav. Neurosci. 8:325. doi: 10.3389/fnbeh.2014.00325
39. Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., and Watanabe, M. (2009). Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev.89, 309-380. doi: 10.1152/physrev.00019.2008
40. Kathmann, M., Bauer, U., Schlicker, E., and Göthert, M. (1999). Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Naunyn Schmiedebergs Arch. Pharmacol. 359, 466-470. doi: 10.1007/pl00005377
41. Kiyasova, V., Bonnavion, P., Scotto-Lomassese, S., Fabre, V., Sahly, I., Tronche, F., et al. (2013). A subpopulation of serotonergic neurons that do not express the 5-HT1A autoreceptor. ACS Chem. Neurosci. 4, 89-95. doi: 10.1021/cn300157s
42. Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., et al. (2003). CB1 cannabinoid receptors and on-demand defense against excitotoxicity.Science 302, 84-88. doi: 10.1126/science.1088208
43. Marsicano, G., and Lutz, B. (1999). Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11, 4213-4225. doi: 10.1046/j.1460-9568.1999.00847.x
44. Monory, K., Massa, F., Egertová, M., Eder, M., Blaudzun, H., Westenbroek, R., et al. (2006). The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51, 455-466. doi: 10.1016/j.neuron.2006.07.006
45. Moreira, F. A., Grieb, M., and Lutz, B. (2009). Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. Best Pract. Res. Clin. Endocrinol. Metab. 23, 133-144. doi: 10.1016/j.beem.2008.09.003
46. Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., et al. (2004). Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 3, 287-302. doi: 10.1111/j.1601-1848.2004.00076.x
47. Nakazi, M., Bauer, U., Nickel, T., Kathmann, M., and Schlicker, E. (2000). Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.Naunyn-Schmiedebergs Arch. Pharmacol. 361, 19-24. doi: 10.1007/s002109900147
48. Petit-Demouliere, B., Chenu, F., and Bourin, M. (2005). Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 177, 245-255. doi: 10.1007/s00213-004-2048-7
49. Pietropaolo, S., Delage, P., Cayzac, S., Crusio, W. E., and Cho, Y. H. (2011). Sex-dependent changes in social behaviors in motor pre-symptomatic R6/1 mice. PLoS One 6:e19965. doi: 10.1371/journal.pone.0019965
50. Pollak Dorocic, I., Fürth, D., Xuan, Y., Johansson, Y., Pozzi, L., Silberberg, G., et al. (2014). A whole-brain atlas of inputs to serotonergic neurons of the dorsal and median raphe nuclei. Neuron 83, 663-678. doi: 10.1016/j.neuron.2014.07.002
51. Ramikie, T. S., Nyilas, R., Bluett, R. J., Gamble-George, J. C., Hartley, N. D., Mackie, K., et al. (2014). Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses. Neuron 81, 1111-1125. doi: 10.1016/j.neuron.2014.01.012
52. Ruehle, S., Rey, A. A., Remmers, F., and Lutz, B. (2012). The endocannabinoid system in anxiety, fear memory and habituation. J. Psychopharmacol. 26, 23-39. doi: 10.1177/0269881111408958
53. Ruehle, S., Remmers, F., Romo-Parra, H., Massa, F., Wickert, M., Wörtge, S., et al. (2013). Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions. J. Neurosci. 33, 10264-10277. doi: 10.1523/JNEUROSCI.4171-12.2013
54. Steiner, M. A., Marsicano, G., Wotjak, C. T., and Lutz, B. (2008). Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. Psychoneuroendocrinology 33, 1165-1170. doi: 10.1016/j.psyneuen.2008.06.004
55. Tang, Y. P., Shimizu, E., Dube, G. R., Rampon, C., Kerchner, G. A., Zhuo, M., et al. (1999). Genetic enhancement of learning and memory in mice. Nature 401, 63-69. doi: 10.1038/43432
56. Tordera, R. M., Totterdell, S., Wojcik, S. M., Brose, N., Elizalde, N., Lasheras, B., et al. (2007). Enhanced anxiety, depressive-like behavior and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur. J. Neurosci. 25, 281-290. doi: 10.1111/j.1460-9568.2006.05259.x
57. Urigüen, L., Pérez-Rial, S., Ledent, C., Palomo, T., and Manzanares, J. (2004). Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors.Neuropharmacology 46, 966-973. doi: 10.1016/j.neuropharm.2004.01.003
58. Vogt, M. A., Chourbaji, S., Brandwein, C., Dormann, C., Sprengel, R., and Gass, P. (2008). Suitability of tamoxifen-induced mutagenesis for behavioral phenotyping.Exp. Neurol. 211, 25-33. doi: 10.1016/j.expneurol.2007.12.012
59. Waider, J., Araragi, N., Gutknecht, L., and Lesch, K. P. (2011). Tryptophan hydroxylase-2 (TPH2) in disorders of cognitive control and emotion regulation: a perspective. Psychoneuroendocrinology 36, 393-405. doi: 10.1016/j.psyneuen.2010.12.012
60. Wallmichrath, I., and Szabo, B. (2002). Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse. Neuroscience 113, 671-682. doi: 10.1016/s0306-4522(02)00109-4
61. Weber, T., Böhm, G., Hermann, E., Schütz, G., Schönig, K., and Bartsch, D. (2009). Inducible gene manipulations in serotonergic neurons. Front. Mol. Neurosci. 2:24. doi: 10.3389/neuro.02.024.2009
62. Williams, K., Wheeler, D. M., Silove, N., and Hazell, P. (2010). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst. Rev. 8:CD004677. doi: 10.1002/14651858.CD004677